Literature DB >> 12177166

Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes.

Michiyo Amemiya-Kudo1, Hitoshi Shimano, Alyssa H Hasty, Naoya Yahagi, Tomohiro Yoshikawa, Takashi Matsuzaka, Hiroaki Okazaki, Yoshiaki Tamura, Yoko Iizuka, Ken Ohashi, Jun-ichi Osuga, Kenji Harada, Takanari Gotoda, Ryuichiro Sato, Satoshi Kimura, Shun Ishibashi, Nobuhiro Yamada.   

Abstract

Recent studies on the in vivo roles of the sterol regulatory element binding protein (SREBP) family indicate that SREBP-2 is more specific to cholesterogenic gene expression whereas SREBP-1 targets lipogenic genes. To define the molecular mechanism involved in this differential regulation, luciferase-reporter gene assays were performed in HepG2 cells to compare the transactivities of nuclear SREBP-1a, -1c, and -2 on a battery of SREBP-target promoters containing sterol regulatory element (SRE), SRE-like, or E-box sequences. The results show first that cholesterogenic genes containing classic SREs in their promoters are strongly and efficiently activated by both SREBP-1a and SREBP-2, but not by SREBP-1c. Second, an E-box containing reporter gene is much less efficiently activated by SREBP-1a and -1c, and SREBP-2 was inactive in spite of its ability to bind to the E-box. Third, promoters of lipogenic enzymes containing variations of SRE (SRE-like sequences) are strongly activated by SREBP-1a, and only modestly and equally by both SREBP-1c and -2. Finally, substitution of the unique tyrosine residue within the basic helix-loop-helix (bHLH) portion of nuclear SREBPs with arginine, the conserved residue found in all other bHLH proteins, abolishes the transactivity of all SREBPs for SRE, and conversely results in markedly increased activity of SREBP-1 but not activity of SREBP-2 for E-boxes. These data demonstrate the different specificity and affinity of nuclear SREBP-1 and -2 for different target DNAs, explaining a part of the mechanism behind the differential in vivo regulation of cholesterogenic and lipogenic enzymes by SREBP-1 and -2, respectively.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12177166

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  112 in total

1.  Chronic exposure to low-dose arsenic modulates lipogenic gene expression in mice.

Authors:  Adeola O Adebayo; Fokko Zandbergen; Courtney D Kozul-Horvath; Philip A Gruppuso; Joshua W Hamilton
Journal:  J Biochem Mol Toxicol       Date:  2014-08-23       Impact factor: 3.642

Review 2.  Potential mechanisms of atypical antipsychotic-induced hypertriglyceridemia.

Authors:  Hu Yan; Jin-Dong Chen; Xiao-Yan Zheng
Journal:  Psychopharmacology (Berl)       Date:  2013-07-06       Impact factor: 4.530

3.  Sterol Regulatory Element Binding Protein Regulates the Expression and Metabolic Functions of Wild-Type and Oncogenic IDH1.

Authors:  Stéphane J H Ricoult; Christian C Dibble; John M Asara; Brendan D Manning
Journal:  Mol Cell Biol       Date:  2016-08-26       Impact factor: 4.272

4.  Role of pyruvate kinase M2 in oxidized LDL-induced macrophage foam cell formation and inflammation.

Authors:  Amit Kumar; Priya Gupta; Minakshi Rana; Tulika Chandra; Madhu Dikshit; Manoj Kumar Barthwal
Journal:  J Lipid Res       Date:  2020-01-27       Impact factor: 5.922

Review 5.  Brick by brick: metabolism and tumor cell growth.

Authors:  Ralph J Deberardinis; Nabil Sayed; Dara Ditsworth; Craig B Thompson
Journal:  Curr Opin Genet Dev       Date:  2008-04-02       Impact factor: 5.578

6.  Small Heterodimer Partner Regulates Dichotomous T Cell Expansion by Macrophages.

Authors:  Sayyed Hamed Shahoei; Young-Chae Kim; Samuel J Cler; Liqian Ma; Sayeepriyadarshini Anakk; Jongsook K Kemper; Erik R Nelson
Journal:  Endocrinology       Date:  2019-07-01       Impact factor: 4.736

7.  Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/β-catenin Pathway.

Authors:  Hyeon Jeong Lee; Jie Li; Renee E Vickman; Junjie Li; Rui Liu; Abigail C Durkes; Bennett D Elzey; Shuhua Yue; Xiaoqi Liu; Timothy L Ratliff; Ji-Xin Cheng
Journal:  Mol Cancer Res       Date:  2018-03-15       Impact factor: 5.852

8.  The citrus flavonoids hesperetin and nobiletin differentially regulate low density lipoprotein receptor gene transcription in HepG2 liver cells.

Authors:  Brian Morin; LaNita A Nichols; Katherine M Zalasky; J Wade Davis; John A Manthey; Lené J Holland
Journal:  J Nutr       Date:  2008-07       Impact factor: 4.798

9.  Membrane cholesterol as regulator of human rhomboid protease RHBDL4.

Authors:  Sandra Paschkowsky; Sherilyn Junelle Recinto; Jason C Young; Ana-Nicoleta Bondar; Lisa Marie Munter
Journal:  J Biol Chem       Date:  2018-08-24       Impact factor: 5.157

Review 10.  The interplay between cell signalling and the mevalonate pathway in cancer.

Authors:  Peter J Mullen; Rosemary Yu; Joseph Longo; Michael C Archer; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2016-08-26       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.